BioTissue’s Sharing Miracles and Mount Sinai Medical Center Create Direct Acquisition Program to Expand Birth Tissue Donation

MIAMI, March 25, 2025—BioTissue announced today that its birth tissue donation program, Sharing Miracles, will collaborate with Mount Sinai Medical Center to launch a groundbreaking program designed to streamline the birth tissue donation process at the Miami hospital. Founded by BioTissue, Sharing Miracles is a caring and supportive program that educates expectant mothers about the benefits birth tissue doation provides to patients in need of regenerative therapies. As stewarts of the gift, they honor the decision to donate, and ensure the process is conducted with the utmost levels of integrity and compliance to maximize the positive impact on the patients they serve. The Sharing Miracles Team has over three decades of experience working with organ, eye, and tissue donation organizations and hospitals across the nation.

Through this partnership, the Sharing Miracles team will assist Mount Sinai Medical Center in managing and facilitating every aspect of the donor consent, screening, and collection process. Their onsite presence will enable collaboration with the Labor & Delivery unit, allowing them to educate mothers about the opportunity to donate their birth tissue.

“We are excited to partner with Mount Sinai Medical Center to expand placenta & umbilical cord donation throughout South Florida, offering the opportunity of donation to expectant mothers, who in turn can help us transform the miracle of life into someone else’s real life miracle. We like to say that coming into this world, these babies have already made a difference, igniting a legacy of hope & healing for someone in need of regenerative therapies. Ultimately, the goal is to heal more patients together through donation & transplantation. We couldn’t be more honored to be a part of that process,” said Julie Caldro, Senior Director of Tissue Procurement, BioTissue. “We are grateful for the precious gifts from mothers who make our work possible and we are committed to setting the standards that define next generation care for the donors & patients we serve.”

Sharing Miracles offers mothers the opportunity to donate their placenta and umbilical cord for use in regenerative healing products. Grafts made from this birth tissue are commonly used to support wound healing in their use and to treat a wide range of other conditions. Patients with neurotrophic keratitis, dry eye, diabetic foot ulcers, osteoarthritis, and chronic and non-healing wounds may all benefit from these tissues, and one tissue donation can transform the lives of up to 75 people.

“At Mount Sinai Medical Center, we are fortunate to partner with BioTissue, offering families the opportunity to donate their placentas,” said Kylie Rowlands Perez, Assistant Vice President of Nursing for Maternal Child Health at Mount Sinai Medical Center. “It gives families the chance to provide life-changing benefits to others. It’s the perfect way to extend the joy of new life and make a meaningful difference in the world.”

For more information about Sharing Miracles, visit www.sharingmiracles.com.

# # #

About Sharing Miracles

Sharing Miracles was established to provide a supportive program for mothers to donate birth tissue. For more information, visit www.sharingmiracles.com.

About BioTissue Holdings Inc.

BioTissue is an emerging biotechnology company and leader in harnessing the unique power of human birth tissue to support regenerative healing for ocular surface disease and in surgical, chronic wound, and musculoskeletal applications. BioTissue’s portfolio of Cryopreserved Amniotic Membrane (CAM) products use its proprietary CryoTek® cryopreservation technology, designed to retain the tissue’s structural and functional integrity. The company continues to break new ground with multiple investigational new drug clinical trials as the company pursues Biologic License Applications (BLAs) for products to treat patients’ unmet clinical needs. BioTissue is committed to empowering healthcare professionals with solutions to deliver optimal patient outcomes by fostering innovation through evidence-based science. Since its inception, clinicians have performed over 1 million human implants with its products and published 420 peer-reviewed publications supporting BioTissue’s platform technology. Learn more at biotissue.com.

Media Contact

Wendy Boyce

McDougall Communications for BioTissue

[email protected] or (585) 752-5805

Mount Sinai Medical Center Contacts

Jackie Kaplan – [email protected]

Riley Caverly – [email protected]